Lotus Pharmaceuticals, Inc. (LTUS)

Lotus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Sep 30, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006
Cash & Equivalents	0.16	1.34	3.95	1.28	4.56	2.09
Cash & Short-Term Investments	0.16	1.34	3.95	1.28	4.56	2.09
Cash Growth	-82.30%	-66.04%	208.55%	-71.94%	118.17%	-
Accounts Receivable	6	1.97	1.78	6.13	20.43	7.28
Other Receivables	-	-	-	2.04	-	-
Receivables	6	1.97	1.78	8.18	20.43	7.28
Inventory	1.27	0.63	1.04	3.79	3.41	3.13
Prepaid Expenses	0.13	0.58	0.86	0.12	1.01	0.25
Other Current Assets	0	0.02	0.07	0.4	0.03	-
Total Current Assets	7.56	4.54	7.69	13.76	29.44	12.75
Property, Plant & Equipment	52.28	39.34	16.22	6.9	6.17	5.81
Other Intangible Assets	20.28	20.54	49.89	1.89	1.29	1.35
Long-Term Deferred Charges	-	-	-	0.07	-	-
Other Long-Term Assets	40.04	38.77	10.57	41.09	-	1.83
Total Assets	120.16	103.18	84.38	63.71	36.9	21.74
Accounts Payable	0	0.04	-	0.9	0.76	0.71
Accrued Expenses	12.15	5.94	5.64	5.52	0.29	2.05
Short-Term Debt	0.77	0.74	0.72	-	2.6	0.93
Current Portion of Long-Term Debt	-	-	4.17	-	-	-
Current Income Taxes Payable	-0.06	-0.06	0.37	-	0.57	-
Current Unearned Revenue	0.53	0.5	1.16	0.57	0.56	0.66
Other Current Liabilities	0.81	0.88	0.59	1.99	-	-
Total Current Liabilities	14.2	8.05	12.65	8.98	4.79	4.34
Long-Term Debt	5.41	5.24	5.07	8.71	5.48	5.59
Other Long-Term Liabilities	1.09	0.87	0.87	0.89	-	-
Total Liabilities	20.7	14.16	18.58	18.57	10.26	9.93
Common Stock	0.03	0.03	0.02	0.04	0.04	0.04
Additional Paid-In Capital	23.81	21.68	15.67	11.55	8.1	5.97
Retained Earnings	65.41	60.17	45.74	29.31	16.52	5.3
Comprehensive Income & Other	10.21	7.15	4.36	4.23	1.98	0.5
Total Common Equity	99.45	89.02	65.8	45.13	26.64	11.81
Shareholders' Equity	99.45	89.02	65.8	45.13	26.64	11.81
Total Liabilities & Equity	120.16	103.18	84.38	63.71	36.9	21.74
Total Debt	6.18	5.99	9.96	8.71	8.07	6.52
Net Cash (Debt)	-6.02	-4.65	-6.01	-7.43	-3.51	-4.43
Net Cash Per Share	-0.22	-0.17	-0.24	-0.31	-0.16	-0.22
Filing Date Shares Outstanding	27.82	27.75	23.65	21.21	20.9	20.64
Total Common Shares Outstanding	27.8	26.76	23.65	21.21	20.9	20.64
Working Capital	-6.64	-3.51	-4.95	4.79	24.65	8.42
Book Value Per Share	3.58	3.33	2.78	2.13	1.27	0.57
Tangible Book Value	79.17	68.48	15.91	43.24	25.35	10.46
Tangible Book Value Per Share	2.85	2.56	0.67	2.04	1.21	0.51
Buildings	-	-	2.34	2.33	2.94	2.39
Machinery	6.23	6.03	5.83	5.81	5.19	4.85
Construction In Progress	56.75	36.1	10.9	1.18	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.